DJIA 17,619.51 23.16 0.13%
NASDAQ 4,986.87 28.40 0.57%
S&P 500 2,063.11 5.47 0.27%
market minute promo

AbbVie Inc. (NYSE: ABBV)

67.19 0.01 (0.01%)

Quote as of

Extended Hours: $67.19 $0.00 (0.00%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

ABBV $67.19 0.01%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $68.00
Previous Close $67.18
Daily Range $66.66 - $68.22
52-Week Range $51.37 - $70.76
Market Cap $107.0B
P/E Ratio 59.98
Dividend (Yield) $2.04 (3.0%)
Ex-Dividend Date
Dividend Pay Date
07/13/15
08/14/15
Volume 11,625,558
Average Daily Volume 11,144,981
Current FY EPS $4.27

Sector

Industry

AbbVie Inc. (ABBV) Description

AbbVie Inc. Website: http://www.abbvie.com/

News & Commentary Rss Feed

3 Biotech Stocks to Buy As the Greek Tragedy Unfolds

Exelixis, Enanta Pharmaceuticals, and Isis Pharmaceuticals are three names in biotech I'm closely watching in case they fall as a result of the financial crisis in Greece.

Premarket Biotech Digest: Celgene-Juno, AbbVie Rx Data, FDA-Gilead Lawsuit

Enanta is growing thanks to collaborations.

Water-Logged And Getting Wetter: AbbVie (ABBV)

Evercore ISI Analyst Breaks Down Amgen's IPR Against AbbVie's Humira Formulation Patent

Noteworthy ETF Outflows: JKD, ABBV, USB, ABT

Better Dividend Stock: AbbVie or Johnson & Johnson?

AbbVie and Johnson & Johnson are widely recognized as top-tier dividend stocks. Here is a look at which one offers the better long-term prospects for income-seeking investors.

Premarket Biotech Digest: Trouble For Stryker Sub's Ex-CEO; Zoetis Merger Rumors

June 29 Premarket Biotech Digest: Trouble For Stryker Sub's Ex-CEO; Veracyte-Aetna Agreement; Zoetis

June 29 Premarket Biotech Digest: Trouble For Stryker Sub's Ex-CEO; Veracyte-Aetna Agreement; Zoetis Merger Rumors

Stocks to Watch in Hep-C Drugs

These are the top hep-C drugmakers vying for share in this multibillion-dollar market.

See More ABBV News...